Western blotting, real-time PCR, and immunohistochemical analyses confirmed that mangiferin activated the AMPK signaling pathway and inhibited activation of the NLRP3 inflammasome, a key mediator of inflammation and pyroptosis in NAFLD. The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatotic liver disease.